SS Innovations International (NASDAQ:SSII) shares rose 3.86% in pre-market trading to $4.04, up from a prior close of $3.89, as investors continued digesting record second quarter 2026 results reported August 13. Revenue rose 39.4% year-over-year to $13.9 million, with installations of the company's SSi …
EyePoint Pharmaceuticals (NASDAQ:EYPT) shares plunged 64.01% in pre-market trading to $5.31, down from a prior close of $14.75, and trading in the stock was halted after the company disclosed that its experimental eye drug, DURAVYU, failed to meet its primary endpoint in the LUGANO …
The dollar fell to its lowest level in more than two months Monday as traders trimmed bets on a Federal ReserveInterest Ratehike following a run of softer US economic data. The euro touched a two-month high around $1.1614, last up 0.3% on the day, …
Representatives of the Trump administration met with mediators from Egypt, Qatar, and Turkey in Cairo as part of a continuing effort to move the president's Gaza peace initiative forward. The talks included representatives from Hamas at certain points, according to a diplomat familiar with …
Japan's 10-year government bond yield jumped to 2.93% on Monday, reaching its highest level since 1996, as traders increasingly bet the Bank of Japan will raise interest rates as soon as September. The move came even as data showed Japan's economy grew more slowly …
Oil held its ground above $82 a barrel as traders balanced growing geopolitical risk against the absence of any confirmed large-scale disruption to physical crude supply. A fresh round of fighting in Lebanon, combined with attacks on commercial vessels navigating the Strait of Hormuz, …
President Donald Trump has directed the Pentagon to substantially cut back joint military exercises with South Korea, a longtime treaty ally, arguing the drills are costly and unnecessary given what he called a non-threatening posture from North Korea. The order came just hours ahead …
● Teads Holding shares changed hands near $0.59 to $0.67 in mid-August 2026, down roughly 60% over the past year.
● VolitionRx Limited filed its second-quarter 10-Q on August 13, 2026 and hosted anEarnings Callthe following morning.
● Vivos Therapeutics reported second-quarter 2026 results on August 14 showing 35% year-over-yearRevenuegrowth.